Cardiovascular mortality · people with diabetes and kidney disease
Angiotensin receptor blockers showed no clear difference in cardiovascular death Median compared with placebo or no treatment (low certainty).
1 finding from 1 review
Death (any cause) · adults with early (stage 1 to 3) non‐diabetic CKD
1 finding from 1 review
Cardiovascular events · adults with early (stage 1 to 3) non‐diabetic CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants reporting an adverse event · adults with early (stage 1 to 3) non‐diabetic CKD
It is very uncertain whether angiotensin receptor blockers changes adverse events (number reporting an adverse event) compared with placebo (very low certainty).
1 finding from 1 review
Kidney failure progression: eGFR (mL/min/1.73m²) · adults with early (stage 1 to 3) non‐diabetic CKD
1 finding from 1 review
All‐cause mortality · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
It is very uncertain whether ACEIs or ARBs changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
Risk of acute myocardial ischaemia · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
It is very uncertain whether ACEIs or ARBs changes risk of acute myocardial ischaemia compared with placebo (very low certainty).
1 finding from 1 review
Congestive heart failure · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
1 finding from 1 review
Hypotension · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
It is very uncertain whether ACEIs or ARBs changes hypotension compared with placebo (very low certainty).
1 finding from 1 review
Rate of perioperative cerebrovascular complications · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
It is very uncertain whether ACEIs or ARBs changes rate of perioperative cerebrovascular complications compared with placebo (very low certainty).
1 finding from 1 review
Length of hospital stay · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
1 finding from 1 review
Treatment related adverse events · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
1 finding from 1 review
Residual kidney function (24 months) · patients receiving PD
4 findings from 1 review
no estimate extracted
1 study · 44 participants
Moderate
no estimate extracted
1 study · 44 participants
Moderate
no estimate extracted
3 studies · 110 participants
Moderate
Show 1 more finding
Diastolic blood pressure · patients receiving PD
1 finding from 1 review
Serum potassium · patients receiving PD
1 finding from 1 review
Peritonitis · patients receiving PD
Angiotensin receptor blockers (ARBs) showed no clear difference in adverse events (episodes of peritonitis) compared with conventional therapy (low certainty).
1 finding from 1 review
Residual kidney function (12 months) · patients receiving PD
1 finding from 1 review
Urinary protein excretion · patients receiving PD
1 finding from 1 review
Kt/V · patients receiving PD
1 finding from 1 review
Creatinine clearance · patients receiving PD
1 finding from 1 review